| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/19/2007 | CN101037674A Rebuilt gland virus containing BMP-7 gene and usage thereof |
| 09/19/2007 | CN101037673A Tobacco virus abrasive paper frictional inoculation method |
| 09/18/2007 | US7270997 Genetically engineered attenuated coxsackievirus virion for use as tool in immunotherapy |
| 09/18/2007 | US7270990 Virus production |
| 09/18/2007 | US7270825 Production of a parvovirus vaccine in plants as viral coat protein fusions |
| 09/18/2007 | US7270812 Pharmaceutical composition for treatment of cancers |
| 09/18/2007 | US7270811 Recombinant replication-defective adenovirus serotypes 11, 25, 34, 35, 48 and 49 as gene delivery vehicles for gene therapy; reduced drug resistance, increased effectiveness of vaccination |
| 09/18/2007 | CA2185541C Cytotoxic t-cell epitopes |
| 09/18/2007 | CA2137161C Nucleic acids and methods of use thereof for controlling viral pathogens |
| 09/16/2007 | CA2539902A1 Method of enhancing degradation of chitin |
| 09/15/2007 | CA2579507A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/15/2007 | CA2545597A1 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof |
| 09/13/2007 | WO2007101657A1 Hepatitis c virus non structural fusion protein |
| 09/13/2007 | WO2003072719A3 Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences |
| 09/13/2007 | US20070212770 Oligopeptide-free cell culture media |
| 09/13/2007 | US20070212727 Microorganisms for therapy |
| 09/13/2007 | US20070212684 Diagnostic Test Kits |
| 09/13/2007 | US20070212377 Viral particle comprising nucleotide sequences coding gB gene of infectious laryngotracheitis virus for use in generation of vaccine to prevent respiratory system disorders |
| 09/13/2007 | US20070212376 Method of treating and preventing infectious diseases |
| 09/13/2007 | US20070212375 Process For Producing In Yeast Empty Viral Capsids Consisting Of Proteins Derived From Pvp2 Of The Infectious Bursal Disease Virus (Ibdv) |
| 09/13/2007 | US20070212374 Stable (fixed) forms of viral capsid proteins, and viral capsid protein fusions, preferably papillomavirus l1 proteins, and uses thereof |
| 09/13/2007 | CA2645177A1 Hepatitis c virus non structural fusion protein |
| 09/12/2007 | EP1831381A1 Methods to obtain recombinant proteins with increased sialylation from cells that express adenovirus e1a protein, and proteins obtained thereby |
| 09/12/2007 | EP1831357A1 Rescue of influenza virus |
| 09/12/2007 | EP1230347B1 Method for the preparation of purified hcv rna by exosome separation |
| 09/12/2007 | CN101035906A Telomelysin-GFP gene-containing recombinant virus |
| 09/12/2007 | CN101033464A Recombination adenovirus for expressing human particle cytolysin and its preparing method and use |
| 09/12/2007 | CN100336902C Isolated phages and their use in food or pet food products |
| 09/11/2007 | US7268227 Posh nucleic acids, polypeptides and related methods |
| 09/11/2007 | US7267952 Method of extracting virus genes and extraction apparatus |
| 09/11/2007 | US7267825 Suitable for gene therapy |
| 09/11/2007 | US7267823 Administering to a mammal an immunogenic formulation containing an Ebola peptide, to induce a protective cytotoxic T lymphocyte response |
| 09/11/2007 | CA2475337C Methods for cultivating cells and propagating viruses |
| 09/11/2007 | CA2204357C Novel adenoviral vectors, packaging cell lines, recombinant adenoviruses and methods |
| 09/07/2007 | CA2617600A1 Attenuated reovirus |
| 09/06/2007 | US20070207546 Bovine immunodeficiency virus (biv) based vectors |
| 09/06/2007 | US20070207502 Cyclic peptides |
| 09/06/2007 | US20070207461 Virus Purification Methods |
| 09/06/2007 | US20070207454 Novel method to identify targets for antibiotic development |
| 09/06/2007 | US20070207167 Immunologically enhanced recombinant vaccines |
| 09/05/2007 | EP1828390A2 Chimeric vectors |
| 09/05/2007 | EP1453535B1 Enveloped virus vaccine and method for production |
| 09/05/2007 | CN101031651A Cell for producing retrovirus vector |
| 09/05/2007 | CN100335619C Method for large scale production of virus antigen |
| 09/05/2007 | CN100335131C Recombinant herpesvirus of turkeys and use thereof |
| 09/04/2007 | US7265280 Polynucleotides encoding carnation senescence-induced DHS |
| 09/04/2007 | US7264958 Method for obtaining a purified viral preparation |
| 09/04/2007 | US7264957 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV |
| 09/04/2007 | US7264923 Infected macrophage that is deficient in a STAT-1-dependent anti-viral pathway, an interferon receptor-dependent anti-viral pathway, and/or a double-stranded RNA-dependent serine/threonine protein kinase-dependent anti-viral pathway |
| 09/04/2007 | US7264818 BAV packaging regions and E1 transcriptional control regions |
| 09/04/2007 | US7264816 an isolated unusually virulent form of a calicivirus that results in a highly contagious and fatal hemorrhagic fever syndrome; immunizing cats; vaccines; detecting in a sample |
| 09/04/2007 | US7264814 wherein at least one non-essential gene for replication thereof is inactivated; side effect reduction |
| 09/04/2007 | US7264811 Purified active HCV NS2/3 protease |
| 09/04/2007 | US7264804 Kits for detecting anti-SIRS antibodies |
| 09/04/2007 | US7264802 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (PRRSV) |
| 08/30/2007 | WO2007097820A2 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/30/2007 | WO2007096185A1 Primate model for orthopox virus infections |
| 08/30/2007 | WO2007035082A9 Immortalized fetal liver cell lines |
| 08/30/2007 | WO2005037856A3 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
| 08/30/2007 | US20070202593 Cell-Targeted IKB and Methods for the Use Thereof |
| 08/30/2007 | US20070202587 Recombinant AAV production in mammalian cells |
| 08/30/2007 | US20070202572 Microorganisms for therapy |
| 08/30/2007 | US20070202505 Methods for gene function analysis |
| 08/30/2007 | DE19627193B4 Rekombinantes myxomatisches Virus Recombinant virus myxomatisches |
| 08/30/2007 | DE102006004154A1 Method for proviral activation, comprises addition of calcineurin inhibitors cyclosporin A or tacrolimus to latent virus-infected cell populations or cell aggregates of e.g. animals, to activate viral nucleic acid and protein formation |
| 08/30/2007 | CA2645414A1 Method for screening hiv drug sensitivity |
| 08/30/2007 | CA2643819A1 Pseudoinfectious flavivirus and uses thereof |
| 08/30/2007 | CA2630218A1 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/29/2007 | EP1826264A1 Primate model for orthopox virus infections |
| 08/29/2007 | EP1824990A2 Methods of producing influenza vaccine compositions |
| 08/29/2007 | EP1047301B1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 08/29/2007 | EP1032269B1 Treatment of neoplasms with interferon-sensitive, clonal viruses |
| 08/29/2007 | EP0953039B1 Animal models of human prostate cancer progression |
| 08/29/2007 | CN101024845A 方法 Method |
| 08/29/2007 | CN101024824A A method for the inactivation and removal of dengue virus from biological samples |
| 08/29/2007 | CN101024823A Method for producing composite biological bacteriophage |
| 08/29/2007 | CN100334217C Recombinant chicken Marek's disease virus transfer vector and application thereof |
| 08/28/2007 | US7262342 FUS6 nucleic acid molecules and methods of their use in enhancing disease resistance in plants |
| 08/28/2007 | US7262270 Ectodomain of the HIV-1IIIB envelope glycoprotein gp41 fused to a fragment of the influenza virus HA2 hemagglutinin protein. Immunization in vivo via an intraperitoneal prime followed by intranasal or intragastric boosts with gp41HA |
| 08/28/2007 | US7262049 Expression vector for use in the transfer of genetic material in cells |
| 08/28/2007 | US7262045 Methods of producing influenza vaccine compositions |
| 08/28/2007 | US7262033 Cell lines for the propagation of mutated herpes viruses |
| 08/28/2007 | US7261883 Vaccines containing ribavirin and methods of use thereof |
| 08/28/2007 | US7261544 Using ligand conjugated matrix to isolate functional adenoassociated viral particles from solution |
| 08/28/2007 | CA2124460C Production of anti-self antibodies from segment repertoires and displayed on phage |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/23/2007 | WO2007095616A2 Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 08/23/2007 | WO2007093472A1 Dengue chimeric viruses |
| 08/23/2007 | WO2002018595A9 Moraxella polypeptides and corresponding dna fragments and uses thereof |
| 08/23/2007 | US20070199102 Isolated Nucleic Acid Molecules From The Genome Of Citrus Sudden Death Virus And Uses Thereof |
| 08/23/2007 | US20070196922 Methods and Compositions Relating to Restricted Expression Lentiviral Vectors and Their Applications |
| 08/23/2007 | US20070196390 Equine herpesvirus vaccine |
| 08/23/2007 | US20070196389 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/23/2007 | US20070196388 Cold-adapted equine influenza viruses |
| 08/23/2007 | US20070196387 Novel assay for the separation and quantification of hemagglutinin antigens |
| 08/23/2007 | US20070196338 Heparin and heparan sulfate binding chimeric vectors |
| 08/23/2007 | US20070196336 Method For Constructing Recombinant Herpes Simplex Virus |
| 08/23/2007 | CA2633005A1 Dengue chimeric viruses |
| 08/22/2007 | EP1820858A1 Chimeric protein comprising micro-protein having two or more disulfide bonds and embodiments thereof |
| 08/22/2007 | EP1820853A2 Recombinant influenza viruses for vaccines and gene therapy |